Kyocera Corporation announced that its U.S. headquarters has finalized an agreement with Renovis Surgical Technologies, Inc.
Source: www.businesswire.com
Kyocera Corp, a Japanese manufacturer of medical products such as artificial joints and dental implants, announced that its U.S. unit Kyocera International, Inc., is working on a deal with Revonis Surgical Technologies to purchase certain assets. Revonis Surgical Technologies, Inc., is a U.S.-based market leader in 3D-printed implants, and the developer of a broad portfolio of innovative products for orthopedic, neurological, and trauma surgeons. The purchasing assets will include Renovis’ business operations relating to artificial joint and spinal products. The financial terms of the deal are not yet disclosed.
